Literature DB >> 15383626

Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor.

Stephen C Tovey1, Gary B Willars.   

Abstract

Using single cell, real-time imaging, this study compared the impact of members of the B/R4 subfamily of the regulators of G-protein signaling (RGS) (RGS2, -3, and -4) on receptor-mediated inositol 1,4,5-trisphosphate [Ins(1,4,5)P3], diacylglycerol, and Ca2+ signaling. In human embryonic kidney (HEK) 293 cells expressing recombinant Galpha(q/11)-coupled muscarinic M3 receptors, transient coexpression of RGS proteins with fluorescently-tagged biosensors for either Ins(1,4,5)P3 or diacylglycerol demonstrated that RGS2 and 3 inhibited receptor-mediated events. Although gross indices of signaling were unaffected by RGS4, it slowed the rate of increase in Ins(1,4,5)P3 levels. At equivalent levels of expression, myc-tagged RGS proteins showed inhibitory activity on the order RGS3 > or = RGS2 > RGS4. In HEK293 cells, stable expression of myc-tagged RGS2, -3, or -4 at equivalent levels also inhibited phosphoinositide and Ca2+ signaling by endogenously expressed muscarinic M3 receptors in the order RGS3 > or = RGS2 > RGS4. In these cells, RGS2 or -3 reduced receptor-mediated inositol phosphate generation in cell populations and reduced both the magnitude and kinetics (rise-time) of single cell Ca2+ signals. Furthermore, at low levels of receptor activation, oscillatory Ca2+ signals were dampened or abolished, whereas at higher levels, RGS2 and -3 promoted the conversion of more stable Ca2+ elevations into oscillatory signals. Despite little or no effect on responses to maximal receptor activation, RGS4 produced effects on the magnitude, kinetics, and oscillatory behavior of Ca2+ signaling at submaximal levels that were consistent with those of RGS2 and -3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383626     DOI: 10.1124/mol.104.005827

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor.

Authors:  Karen Coopman; Yan Huang; Neil Johnston; Sophie J Bradley; Graeme F Wilkinson; Gary B Willars
Journal:  J Pharmacol Exp Ther       Date:  2010-05-27       Impact factor: 4.030

2.  Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling.

Authors:  Barbara Bosier; Pierre J Doyen; Amandine Brolet; Giulio G Muccioli; Eman Ahmed; Nathalie Desmet; Emmanuel Hermans; Ronald Deumens
Journal:  Br J Pharmacol       Date:  2015-10-25       Impact factor: 8.739

3.  β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids.

Authors:  Neil S Holden; Matthew J Bell; Christopher F Rider; Elizabeth M King; David D Gaunt; Richard Leigh; Malcolm Johnson; David P Siderovski; Scott P Heximer; Mark A Giembycz; Robert Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-11       Impact factor: 11.205

4.  Modulation of Gq-protein-coupled inositol trisphosphate and Ca2+ signaling by the membrane potential.

Authors:  Daniela Billups; Brian Billups; R A John Challiss; Stefan R Nahorski
Journal:  J Neurosci       Date:  2006-09-27       Impact factor: 6.167

5.  Role of Cholinergic Innervation and RGS2 in Atrial Arrhythmia.

Authors:  Douglas L Jones; Jari M Tuomi; Peter Chidiac
Journal:  Front Physiol       Date:  2012-06-29       Impact factor: 4.566

6.  Full and partial agonists of muscarinic M3 receptors reveal single and oscillatory Ca2+ responses by beta 2-adrenoceptors.

Authors:  Nisha Kurian; Caroline J Hall; Graeme F Wilkinson; Michael Sullivan; Andrew B Tobin; Gary B Willars
Journal:  J Pharmacol Exp Ther       Date:  2009-05-06       Impact factor: 4.030

7.  Involvement of interleukin-17A-induced hypercontractility of intestinal smooth muscle cells in persistent gut motor dysfunction.

Authors:  Hirotada Akiho; Yohei Tokita; Kazuhiko Nakamura; Kazuko Satoh; Mitsue Nishiyama; Naoko Tsuchiya; Kazuaki Tsuchiya; Katsuya Ohbuchi; Yoichiro Iwakura; Eikichi Ihara; Ryoichi Takayanagi; Masahiro Yamamoto
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

8.  Modulation of hERG potassium currents in HEK-293 cells by protein kinase C. Evidence for direct phosphorylation of pore forming subunits.

Authors:  S L Cockerill; A B Tobin; I Torrecilla; G B Willars; N B Standen; J S Mitcheson
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

9.  The insect repellent N,N-diethyl-m-toluamide (DEET) induces angiogenesis via allosteric modulation of the M3 muscarinic receptor in endothelial cells.

Authors:  Samuel Legeay; Nicolas Clere; Grégory Hilairet; Quoc-Tuan Do; Philippe Bernard; Jean-François Quignard; Véronique Apaire-Marchais; Bruno Lapied; Sébastien Faure
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

10.  Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle.

Authors:  Nooreen Shaikh; Malcolm Johnson; David A Hall; Kian Fan Chung; John H Riley; Sally Worsley; Pankaj K Bhavsar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.